ClinicalTrials.gg
CompletedNCT05697367CHildHNS23Updated Apr 30, 2024

Swiss Childhood Health and Nutrition Survey 2023

An observational study in Childhood Obesity, sponsored by Isabelle Herter-Aeberli. Completed at 1 site in Switzerland. Open to participants aged 6 Years to 12 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-04-30.

Sponsored by Isabelle Herter-Aeberli · Observational

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
1,245
Ages
6 Years to 12 Years
Sex
All
01

Study summary

This study will repeat previous studies done in 2002, 2007 2012 and 2017/18, in order to monitor the trend in the prevalence of overweight and obesity in 6-12 year old children in Switzerland over the entire period. Furthermore, additional risk factors will be assessed for the later development of NCD using a questionnaire comparable to the one used in 2017/18.

Read the detailed description

A total of ca. 2500 children will be recruited throughout Switzerland and their height, weight, waist circumference as well as percentage body fat will be measured. In addition, children will be asked to complete a questionnaire on some aspects of their diet, physical activity, health and socioeconomic background. Data will be compared to previous surveys conducted since 2002 to monitor trends in overweight and obesity prevalence in Switzerland. The results from the questionnaire will be used to investigate risk factors for obesity and the later development of NCDs.

02

Conditions studied

  • Childhood Obesity

Browse trials for

03

In context

Pediatric Obesity

1,129 studies on the registry are indexed under Pediatric Obesity; 187 are open to participants now.

This study's enrollment of 1,245 is above the median of 180 across 235 observational studies indexed under Pediatric Obesity.

Browse Pediatric Obesity studies →

Lead sponsor

Isabelle Herter-Aeberli is the lead sponsor of 13 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
6 Years to 12 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

School aged children living in Switzerland

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • age between 6 and 12 years

Exclusion criteria

Exclusion Criteria:

  • none
05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
1,245 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Prevalence of overweight and obesity

    Based on weight and height measurements BMI-zscores will be calculated for the classification into the different weight status groups.

    Time frame: baseline

Secondary outcomes

  1. waist circumference

    waist circumference in cm

    Time frame: baseline

  2. percent body fat

    percent body fat as calculated from 4 skinfold thickness measures

    Time frame: baseline

  3. physical activity

    Assessed using a questionnaire as hours per week

    Time frame: baseline

  4. Nutrition

    Assessed using a food frequency questionnaire (never to several times a week)

    Time frame: baseline

  5. General health

    Assessed using a questionnaire

    Time frame: baseline

  6. Parental education

    Assessed using a questionnaire on a 5 item scale ranging from obligatory schooling (lowest rating) to university degree (highest rating)

    Time frame: baseline

  7. Country of birth

    Assessed in a questionnaire

    Time frame: baseline

Other outcomes

  1. Age

    Assessed using a questionnaire, reported by parents

    Time frame: baseline

  2. Sex

    Assessed using a questionnaire

    Time frame: baseline

07

Study locations

1 site
  • ETH Zurich
    Zurich, 8092, Switzerland
08

References and documents

Individual participant data

Plan to share: No — On request, and upon approval, anonymized data can be made available to other researchers.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 30, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05697367
Lead sponsor
Isabelle Herter-Aeberli
Responsible party
Isabelle Herter-Aeberli (Senior Scientist, Swiss Federal Institute of Technology) — Sponsor-investigator
First posted
Jan 25, 2023
Start date
Feb 1, 2023
Primary completion
Dec 31, 2023
Completion
Feb 29, 2024
Last update
Apr 30, 2024

Study contacts

Isabelle Herter-Aeberli, PhD
principal investigator · ETH Zurich

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion